Jin Medical Regains Nasdaq Compliance
Company Announcements

Jin Medical Regains Nasdaq Compliance

Jin Medical International Ltd. (ZJYL) has released an update.

Jin Medical International Ltd. has successfully regained compliance with Nasdaq’s filing requirements by submitting its annual report before the stipulated deadline of May 20, 2024. The company was previously at risk of being delisted but will now remain listed with a condition of continued compliance monitoring until May 9, 2025. Any future non-compliance within this period will lead to an immediate delisting without the option to submit a new compliance plan.

For further insights into ZJYL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskJin Medical’s Asset Growth Amidst Revenue Dip
TipRanks Auto-Generated NewsdeskJin Medical Auditor Resigns Amid Dispute
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!